FDA outlines its intention to overhaul the early-stage clinical development process through a planned Expedited IND Pilot, arguing that the changes are needed to prevent drug development from shifting overseas and to accelerate first-in-human clinical trials in the U.S.
Animal Drugs
Antimicrobial Animal Drug Finalized Safety Guidance
FDA issues a finalized guidance on evaluating the safety of antimicrobial animal drugs based on their role in human medicine.
